Adverse events associated with drug‐related thiamine deficiency: A pharmacovigilance study

Key Points

• The analysis aims to identify connections between certain medications and thiamine deficiency, focusing on safety signals.
• Conducted a pharmacovigilance analysis of adverse event reports.
• Investigated specific medications associated with thiamine deficiency.
• Assessed potential mechanisms such as transport inhibition and metabolic interference.
• Identified specific medications linked to thiamine deficiency.
• Found evidence suggesting mechanisms underlying this deficiency.
• Highlighted the necessity for vigilant thiamine monitoring in high-risk patients.